Pharmaceuticals News and Research

RSS

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Total Nutraceutical Solutions, Inc., announced today that it has received approval for importation of ImmuSANO™ and GlucoSANO™ from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles.

30 Oct 2009

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.

30 Oct 2009

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.

30 Oct 2009

Virtual Pharma Rep 360 Managed Care solution released

Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced the release of Virtual Pharma Rep 360 Managed Care. This module builds on the existing Virtual Pharma Rep virtual sales platform of patent pending technology designed to significantly decrease the marketing, sales and educational expenses in the pharmaceutical sales and education process.

30 Oct 2009

TGen to secure emergency FDA approval for 2009 H1N1 flu test

The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.

30 Oct 2009

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.

30 Oct 2009

Dr. Heather Greene to receive 2009 C.A.R.E. Pharmacy Award

Eisai Inc. and the Alzheimer's Association announce today that Heather Greene, PharmD is the recipient of the 2009 C.A.R.E. Pharmacy Award.

30 Oct 2009

2009 Schering-Plough Excellence Award for WuXi PharmaTech

WuXi PharmaTech (Cayman) Inc., a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had received the 2009 Excellence Award from Schering-Plough.

30 Oct 2009

Pharmaceutical companies accept Ecuador's decision to break drug patents

Foreign pharmaceutical companies on Wednesday accepted the decision of Ecuador's President Rafael Correa to enable the country "to bypass patents on 2,000 drugs in order to produce them locally or buy cheaper versions elsewhere," Agence France-Presse reports.

30 Oct 2009

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

The U.S. will hold off on donating H1N1 (swine flu) vaccine stockpiles to developing countries until "at-risk Americans" receive the vaccine, HHS Secretary Kathleen Sebelius said Wednesday, Agence France-Presse reports

30 Oct 2009

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.

30 Oct 2009

Shocked by re-emergence of public option, business groups push back

Business leaders who thought they had dodged a bullet when the Senate Finance Committee decided against offering a government-run public option as part of their health bill are pushing back after the plan's re-emergence.

29 Oct 2009

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

29 Oct 2009

Allergan reports operating results for the third quarter of 2009

Allergan, Inc. today announced operating results for the quarter ended September 30, 2009. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.

29 Oct 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the “American Recovery and Reinvestment Act of 2009”. The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.

29 Oct 2009

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Gamma Pharmaceuticals Inc. (the "Company") announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China.

29 Oct 2009

Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry

Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer, has been named a 2009 Mass High Tech All Star for his contributions to the pharmaceutical industry.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Endo Pharmaceuticals today reported financial results for the third quarter of 2009.

29 Oct 2009

New herbal medicinal product for reducing mental and physical stress

Marketed under the trade name Vitango® and now available from pharmacies, the product is a special extract of a highly resilient plant called Golden Root (Rhodiola rosea) that grows in the freezing conditions of Northern Europe and Asia's mountain peaks.

29 Oct 2009

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009.

29 Oct 2009

Pharmaceuticals News and Research

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Virtual Pharma Rep 360 Managed Care solution released

TGen to secure emergency FDA approval for 2009 H1N1 flu test

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

Dr. Heather Greene to receive 2009 C.A.R.E. Pharmacy Award

2009 Schering-Plough Excellence Award for WuXi PharmaTech

Pharmaceutical companies accept Ecuador's decision to break drug patents

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Shocked by re-emergence of public option, business groups push back

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Allergan reports operating results for the third quarter of 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

New herbal medicinal product for reducing mental and physical stress

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

Event guide: World ADC London eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring